UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):April 3, 2015
REVOLUTIONS MEDICAL CORPORATION |
(Exact name of registrant as specified in its charter) |
Nevada |
| 000-28629 |
| 73-1526138 |
(State or other jurisdiction of incorporation) |
| (Commission File Number) |
| (IRS Employer Identification No.) |
| 670 Marina Drive, 3rd Floor Charleston, SC 29492 |
|
| (Address of Principal Executive Offices) |
|
(843) 971-4848
Registrant’s telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On April 3, 2015 Judge Leigh Martin May of the U.S. District Court for the Northern District of Georgia issued an order in which she granted in part and denied in part the motion for summary judgment filed by Defendants Revolutions Medical Corporation and its Chief Executive Officer, Rondald Wheet, and denied the motion for partial summary judgment filed by Plaintiff Securities and Exchange Commission in the case styledSEC v. Revolutions Medical Corp, et al. The Court has not scheduled the trial on the claims remaining in the case.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| REVOLUTIONS MEDICAL CORPORATION | |
Date: April 6, 2015 | By: | /s/ Rondald L. Wheet |
|
| Rondald L. Wheet |
|
| Chief Executive Officer |
